Verastem, Inc. (VSTM)
5.70
-0.31
(-5.16%)
USD |
NASDAQ |
May 07, 15:26
Verastem SG&A Expense (TTM) : 81.14M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 24.60B |
| Merck & Co., Inc. | 10.88B |
| Altimmune, Inc. | 28.10M |
| Ocugen, Inc. | 21.13M |
| Xilio Therapeutics, Inc. | 29.71M |